On May 28 in the Morning Capsule that is provided to paid subscribers to The Arora Report, we wrote: Airlines are tracing a double bottom. This is bullish. ETF of interest is JETS. Since then airline stocks have scored major gains. Airline ETF JETS was trading at $16.01 at the
Paid subscribers to The Arora Report receive the Morning Capsule every morning before the market open. They also receive the Afternoon Capsule when market conditions warrant it. Paid subscribers have been receiving the Afternoon Capsule before the market close so that there is still some time to take some action
Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules made available every morning before the market
This post was just published on ZYX Buy Change Alert. MongoDB (MDB) is a data base software stock. It is long from $24. It is trading at $212 as of this writing. This represents 790% gain. MDB remains a buyout candidate. To date, 155 of The Arora Report portfolio companies have
This post was just published on ZYX Buy Change Alert. Overstock.com (OSTK) was bought at $6.61 as part of the January Effect trades. Our call was to hold on to this position for the medium term. The stock is trading at $18.04 as of this writing. Depending upon the account size
Money is beginning to shift away from stocks that did well while the economy shut down to fight coronavirus. The shifts have picked up since Moderna announced impressive data from a Phase 1 trial for a vaccine against coronavirus. Now investors should look ahead to the post-vaccine world: Sell stocks that are
Many investors not familiar with the mechanics of short squeezes are confused by the strength of the stock market rally that began after the S&P 500 hit a coronavirus low on March 23. Short-squeeze-related actions were the force that unleashed the strong rally. As the market continues to rally, the
This post was just published on ZYX Buy Change Alert. Sorrento Therapeutics (SRNE) was purchased at $4.43 on Friday. It traded as high as $10.60 in the pre-market today. The stock has backed off to $9.02 as of this writing. All subscribers should have taken partial profit or profits on the entire
Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules made available every morning before the market
Amid a debate about stock market investors underestimating the risks from the coronavirus-led shutdown of the global economy, China risk is reemerging. How the U.S. responds may determine the direction of the stock market. The U.S. has long contended that Chinese telecommunications-equipment maker Huawei Technologies is a risk to national